Latest filing published 22 Sept 2023 for Glenmark Pharmaceuticals Limited, €9,618.
Filing timeline
BuySalePraveen D Kurkal: trading record in brief
Praveen D Kurkal discloses dealings in Glenmark Pharmaceuticals Limited to SEBI (PIT + SAST). Activity is concentrated on a single trading day, 20 September 2023, with 3 filings.
Every open-market trade on record is a sale: 3 sales worth €24k.
The latest filing, published on 22 September 2023, reports an open-market sale of €9,618 in Glenmark Pharmaceuticals Limited. Between a trade and the moment it shows up on SEBI (PIT + SAST), the median delay is 2 days. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Companies and markets linked to Praveen D Kurkal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ ₹852.0040.0% of flowEquity SharesSEBI:7c43f029fcf65d701002d87cbc38f4b76c05691e
- 1,000 shares@ ₹852.0040.0% of flowEquity SharesSEBI:4735f3b198350556570238ed4d2ffa4d36737a5f
- 500 shares@ ₹851.0220.0% of flowEquity SharesSEBI:e66100d169abd1b49336835c9bcfd5956cdd6833
3 of 3 declarations